openPR Logo
Press release

Global Neuropathy market id driven by increasing obesity rate and rise in diabetic consumers

10-12-2017 11:06 AM CET | Health & Medicine

Press release from: Variant Market Research

Variant Market Research

Variant Market Research

Global Diabetic Neuropathy Market Report, published by Variant Market Research, forecast that the global market is expected to reach $3.8 billion by 2024 from $2.4 billion in 2016; growing at a CAGR of 5.9% from 2016 to 2024.

Diabetic Nephropathy Market (By Mode of Treatment: Drug Modifying Therapies, and Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024

To browse the complete report, visit at https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market

Diabetic neuropathy denotes to the nerve damage caused because of diabetes. The disease most often damages nerves in the feet’s and legs. Though, it can injure nerve fibers throughout the body as well. Diabetic neuropathy is a most common complication of type 1 and type 2 diabetes. Growing diabetic population and increasing awareness among people for diabetes and related difficulties are some of the chief factors that are leading to the growth of diabetic neuropathy market.
Increasing cases of diabetes to drive the Diabetic Neuropathy market

Get Table of Content (TOC) @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market/toc

Some of the drivers or the factors leading to the growth of global diabetic nephropathy market are growing obesity and diabetes among population, mounting investments by major companies for drug discovery & development, rising number of patients suffering from numerous kidney diseases and rising awareness. Moreover, some initiatives by government and NGOs for growing awareness and rising scope of combination therapies would provide several growth opportunities.

Market Segmentation
Mode of treatment, and geography are the major segments of global Diabetic neuropathy market. Mode of treatment segment is further categorized into drug modifying therapies (angiotensin-converting enzyme (ACE) inhibitor, diuretics, calcium channel blockers (CCBs), angiotensin receptor blockers (ARBs), renin inhibitors, connective tissue growth factor inhibitor (CTGF), antioxidant inflammation modulator (AIM), monocyte chemoattractant proteins (MCP) inhibitors, endothelin-A receptors antagonist (ETAR), G protein-coupled receptors (GPCRs) and others) and others. Based on geography, the global diabetic neuropathy market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW).
Asia Pacific is anticipated to grow at a fastest CAGR over the forecast period
Asia Pacific is expected to attain the fastest CAGR during the forecast period 2016-2024, driven by the presence of high number of diabetic population, growing awareness and improving healthcare infrastructure. North America also held the largest market share of 41.1% in 2016, owning to well-developed economy and increasing demand at highest pace in the country.


Click Here to Request a Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/diabetic-nephropathy-market/sample-request

Competitive Landscape
Increasing mergers and acquisitions, quick product launches, and increase in number of collaborations and partnerships are some of the latest trends that have been detected in the global diabetic neuropathy market. Novartis, in 2015, had undergone collaboration with several other producers and supplier of diabetic neuropathy drug producers for expansion of their operations in developing countries.

The major players in the market includes Bayer AG, Novartis AG, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Mesoblast Ltd., Ampio Pharmaceuticals Inc., Reata Pharmaceuticals, GenKyoTex S.A., and ChemoCentryx Inc., among others.

Scope of the Global Diabetic Nephropathy Market
Mode of Treatment Segments
• Drug Modifying Therapies (DMT)
o Angiotensin-Converting Enzyme (ACE) Inhibitor
o Angiotensin Receptor Blockers (ARBs)
o Diuretics
o Calcium Channel Blockers (CCBs)
o Renin Inhibitors
o Connective Tissue Growth Factor Inhibitor (CTGF)
o Antioxidant Inflammation Modulator (AIM)
o Monocyte Chemoattractant Proteins (MCP) Inhibitors
o Endothelin-A Receptors Antagonist (ETAR)
o G Protein-Coupled Receptors (GPCRs)
o Other Drug Modifying Therapies

• Other Mode of Treatments

Geography Segments
• North America
o U.S.
o Canada
o Mexico

• Europe
o UK
o Germany
o France
o Italy
o Other

• Asia-Pacific
o China
o Japan
o India
o South Korea
o Others

• RoW
o South America
o Middle East
o Africa

About Variant Market Research
Variant Market Research offers syndicated and customized reports to fulfill clients' objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.
For further information, visit https://www.variantmarketresearch.com

Contact Us:
Michael Mendes
Head - Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco,
CA 94105,United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: michael.mendes@variantmarketresearch.com
Email: help@variantmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Neuropathy market id driven by increasing obesity rate and rise in diabetic consumers here

News-ID: 769612 • Views:

More Releases from Variant Market Research

Global SCADA Market is Expected to Reach $48 Billion by 2024, Says Variant Marke …
Global SCADA Market Report, published by Variant Market Research, forecast that the global market is expected to reach $48 billion by 2024 from $31 billion in 2016; growing at a CAGR of 5.7% from 2016 to 2024. By geography, Rest of the World (RoW) and Asia Pacific are expected to grow at a CAGR of 6.6% and 6.4%, respectively, during the forecast period. "SCADA Market (By Component: Programmable Logic Control, Human
Global Baby Diapers Industry Outlook: Growth in Per Capita Income to Drive the Market Growth
Global Baby Diapers Industry Outlook: Growth in Per Capita Income to Drive the M …
SAN FRANCISCO, Jun 06, 2018 According to the latest report published by Variant Market Research, the global baby diapers market size is projected to reach $72 Billion by 2024 from $48 Billion in 2016. In this report, baby diapers market forecast says that the global market is growing at 5.1% CAGR from 2016 to 2024.Geographically; Asia Pacific and RoW are expected to grow at a CAGR of 6.8% and 5.8%,
High adoption in End-User Industries Drives Global Corrugated Packaging Market
High adoption in End-User Industries Drives Global Corrugated Packaging Market
SAN FRANCISCO, Jun 06, 2018 According to the latest report published by Variant Market Research, the global corrugated packaging market size is projected to reach $218 million by 2024 from $158 million in 2016. In this report, corrugated packaging market forecast says that the global market is growing at 4.1% CAGR from 2016 to 2024. Click Here to Request a Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/consumer-goods/corrugated-packaging-market/sample-request
Cold Pain Therapy Market is boosted due to increased sports activities
Cold Pain Therapy Market is boosted due to increased sports activities
According to a new report published by Variant Market Research, the global cold pain therapy market size is forecasted to reach $1,185 Million by 2024 from $824 Million in 2016, growing at a CAGR of 4.6% from 2016 to 2024. Geographically, Asia-Pacific and Europe are expected to grow at a CAGR of 6.3% and 4.4%, respectively, during the forecast period says the report. Click Here to Request a Free Sample PDF

All 5 Releases


More Releases for Diabetic

Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report. On the basis of
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282 Global Diabetic Socks Market: Factors Impacting the Market The primary factors driving the growth of the global diabetic socks market are increasing
Expanding Diabetic Populace Driven Growth For Diabetic Food Market Globally
Market Overview Diabetic Food items are dietary items that incorporate diminished starch and sugar substance that assistance in controlling the ascent of the blood glucose. Diabetic Food additionally contains low calorie sweeteners, slim down refreshments, and so on. These items are devoured by diabetic individuals and by the general population who are not diabetic as careful step to avoid diabetes. Diabetic nourishment makers are entering into different market fragments by presenting
Global Diabetic Footwear Market Is Driven By Growing Diabetic Patients Worldwide
Global Diabetic Footwear Market Report, published by Variant Market Research, forecast that the global market is expected to reach $9.4 Billion by 2024 from $5.3 Billion in 2016; growing at a CAGR of 7.4% from 2016 to 2024. To browse the complete report, visit at https://www.variantmarketresearch.com/report-categories/consumer-goods/diabetic-footwear-market Diabetic footwears are used to reduce foot amputation and ulceration risk in people suffering from diabetes. It is a lifestyle disease. Foot ulceration and debilitating
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be